Physician

Ronald Allen Scott, M.D.

According to 2025 Medicare claims, Ronald Scott, M.D. (NPI: 1922118470) practices cardiology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is REGIONAL CLINICS OF LONGVIEW (NPI: 1407047863; TIN: 20-4791426) and primary practice location at 75605-2412. Scott is affiliated with the CHSPSC ACO 8, LLC (ACO ID: A3715) and CVS ACO (ACO ID: A5407), participating under the MSSP model.

Scott's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,699 traditional Medicare patients, billed 8,242 HCPCS/CPT codes, and received $330,836 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 10,763 prescription claims across 1,157 beneficiaries totaling $1,114,570 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 22 claims. Open Payments data shows 145 records totaling $2,399. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $500,045 to $1,114,570. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $9,245 to $6,516.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,116	8,707	$438,419
2016	1,784	7,713	$417,683
2017	1,441	7,605	$436,567
2018	1,041	6,626	$445,024
2019	935	7,101	$431,463
2020	922	6,961	$446,501
2021	878	5,829	$380,811
2022	846	5,243	$351,435
2023	1,352	6,209	$376,024
2024	1,699	8,242	$330,836

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	684	9,783	$500,045
2016	693	10,466	$594,158
2017	732	10,228	$611,067
2018	763	9,624	$602,887
2019	806	9,673	$687,438
2020	852	10,049	$800,109
2021	893	10,300	$950,872
2022	952	10,195	$1,017,788
2023	1,068	10,433	$1,020,969
2024	1,157	10,763	$1,114,570

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	12	$606
2018	N/R	N/R	N/R
2019	N/R	22	$758
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	402	421	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	632	784	$84
93356	Heart muscle strain imaging	197	201	$27
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	410	421	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	784	855	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	467	23,306	$442,028
Xarelto	Rivaroxaban	185	10,070	$185,106
Entresto	Sacubitril/Valsartan	98	5,931	$128,721
Farxiga	Dapagliflozin Propanediol	60	2,861	$53,130
Jardiance	Empagliflozin	52	2,368	$46,538

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	145	$2,399	Biosense Webster, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ronald Allen Scott, M.D.?

Tedicare shows public-source Medicare data for Ronald Allen Scott, M.D. (NPI 1922118470), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ronald Allen Scott, M.D. have ACO affiliation data?

Ronald Allen Scott, M.D. is shown with ACO affiliation data for CHSPSC ACO 8, LLC (MSSP, ACO ID A3715) and CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Ronald Allen Scott, M.D.?

Ronald Allen Scott, M.D. is linked to REGIONAL CLINICS OF LONGVIEW (billing NPI 1407047863) in the available physician profile data.

Does Ronald Allen Scott, M.D. have Open Payments data?

Ronald Allen Scott, M.D. has 145 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.